All Research on Biotechnology in Japan

Insight

Report
Report

Biosimilars: Japan Update

Datamonitor’s report Biosimilars: Japan Update provides analysis on the Japanese biosimilars market. It includes an overview of drivers and resistors to biosimilars uptake, market access strategies, key players, and future development trends.

Published By Datamonitor
$1520
Buy
Report
Report

Pharmaceutical Licensing and Alliances in the Asia-Pacific Region – Pharma enhances its focus on APAC markets

An overview of licensing and alliance trends in developed and emerging pharmaceutical markets in the Asia-Pacific region from Q3 2009 to Q2 2010, including discussion of the drivers of recent deals and analysis of key agreements.

Published By Datamonitor
$2800
Buy

Profiles

Company Profile
Company Profile

Kyowa Hakko Kirin Co., Ltd.

Kyowa Hakko Kirin (KHK or 'the group') is a Japan-based provider of pharmaceuticals and bio-chemicals. The group is a subsidiary of Kirin Holdings Company, which holds 50.1% of KHK's shares. The group is headquartered in Tokyo, Japan, and employed 7,152 people as on December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd. (Chugai or 'the company'), the Japanese subsidiary of the Roche Group, is engaged in biopharmaceutical research and development. It produces antibody drugs primarily focusing on oncology, renal diseases and bone and joint diseases. The company operates in Europe, the Americas and Asia Pacific. It is headquartered in Tokyo, Japan, and employed 6,872 people as of December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

UNITIKA LTD.

Unitika (or 'the group') is engaged in the production of textiles, fibers, and polymers. The group primarily operates in Japan where it is headquartered in Osaka. It employed about 4,534 people as of March 31, 2013.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.